Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Periprosthetic Bone Mineral Density After Total Hip Arthroplasty Performed Through a Minimally Invasive Anterior Approach (AMIS) With Either an AMIStem or a Quadra Femoral Component.

NCT01285843 is registered in ClinicalTrials.gov with Medacta International SA as lead sponsor.

NCT NCT01285843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01285843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Periprosthetic Bone Mineral Density After Total Hip Arthroplasty Performed Through a Minimally Invasive Anterior Approach (AMIS) With Either an AMIStem or a Quadra Femoral Component.
Lead sponsor
Medacta International SA
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2010
Completion date
September 30, 2012
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, avascular necrosis, congenital hip dysplasia, fracture of the femoral neck or head, osteoarthritis